Latam SOLACI-EuroPCR Session

Once more, SOLACI is proud to participate at one of the most important interventional cardiology meetings in the world: the EuroPCR 2019.

Together with our European sister institution, we will conduct an important joint session on “Innovations for the treatment of complex coronary artery lesions from LATAM”, where we will touch upon topics related to STEMI, CTO and coronary interventions.

The activity will take place on Tuesday May 21st in room 252A of Palais des Congress. Pestigious Latin American professionals from SOLACI and Dr. Corrado Tamburino, from Italy, will be there. In this sense, you will be able to enjoy the presentations of doctors José Luis Leiva Pons (SOLACI President, from Mexico), Anibal Damonte (Argentina), Marco Antonio Alcocer Gamba (Mexico), Guering Eid Lidt (Mexico), Alexandre Quadros (Brazil) and Carlos Uribe (Colombia).  

We invite the whole Latin American medical community to participate in this activity, which expresses SOLACI and EuroPCR’s wish to keep deepening their international collaboration, to exchange fruitful experiences that will allow us to advance and improve our patients’ quality of life.

Session Info

  • Tuesday, May 21st, 2019.
  • 12.00 am – 1 pm;
  • Room 252A / Level 2.

More info on this Congress

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....